4B-MAR, 4C-MAR, and 4F-MAR represent a carefully relevant team of novel psychoactive substances (NPS) in the 2-amino-five-aryloxazoline family. They're synthetic stimulants that have emerged as designer drugs, developed as structural analogs with the dad or mum compound four-methylaminorex (4-MAR) to circumvent existing drug scheduling constraints.